Showing results (311-320 of 328) with videos related to
Sort By:
Pageof 33
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2010
Precise correlation between MRI and histopathology - exploring treatment margins for MRI-guided localized breast cancer therapyAnnemarie C Schmitz, Maurice A A J van den Bosch, Claudette E Loo, et al.Bioorganic & Medicinal Chemistry|July 22, 2020
Discovery of [1,2,4]triazolo[4,3-a]pyridines as potent Smoothened inhibitors targeting the Hedgehog pathway with improved antitumor activity in vivoNannan Tian, Huanxian Wu, Huiwu Zhang, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 2, 2012
Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: potential relevance for MRI-guided localized therapyAnnemarie C Schmitz, Kenneth E Pengel, Claudette E Loo, et al.Plos One|August 18, 2018
Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutationsRekha Pal, Ning Wei, Nan Song, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 1999
Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring StudyD Feng, K Lindpaintner, M G Larson, et al.Journal of Molecular Biology|September 28, 2015
The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular ComplexesG C P van Zundert, J P G L M Rodrigues, M Trellet, et al.European Radiology|September 21, 2007
Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular mapsA C Schmitz, N H G M Peters, W B Veldhuis, et al.Proteins|August 6, 2013
Defining the limits of homology modeling in information-driven protein dockingJ P G L M Rodrigues, A S J Melquiond, E Karaca, et al.Cancer Chemotherapy and Pharmacology|January 22, 2025
Phase I trial of ATR inhibitor elimusertib with FOLFIRI in advanced or metastatic gastrointestinal malignancies (ETCTN 10406)Anuradha Krishnamurthy, Hong Wang, John C Rhee, et al.Cancer Chemotherapy and Pharmacology|June 24, 2021
Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumorsWilliam F Maguire, John C Schmitz, Jonas Scemama, et al.Pageof 33